Monsanto (MON) Stake Lessened by Endurance Wealth Management Inc.

Endurance Wealth Management Inc. lessened its stake in shares of Monsanto (NYSE:MON) by 59.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,045 shares of the basic materials company’s stock after selling 4,536 shares during the quarter. Endurance Wealth Management Inc.’s holdings in Monsanto were worth $356,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Havens Advisors LLC lifted its stake in shares of Monsanto by 14.0% in the 4th quarter. Havens Advisors LLC now owns 98,000 shares of the basic materials company’s stock worth $11,444,000 after purchasing an additional 12,000 shares during the period. Schwab Charles Investment Management Inc. lifted its stake in shares of Monsanto by 3.5% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,628,413 shares of the basic materials company’s stock worth $190,167,000 after purchasing an additional 54,336 shares during the period. Creative Planning lifted its stake in shares of Monsanto by 4.2% in the 4th quarter. Creative Planning now owns 26,559 shares of the basic materials company’s stock worth $3,102,000 after purchasing an additional 1,061 shares during the period. Gateway Investment Advisers LLC lifted its stake in shares of Monsanto by 18.2% in the 4th quarter. Gateway Investment Advisers LLC now owns 367,741 shares of the basic materials company’s stock worth $42,945,000 after purchasing an additional 56,734 shares during the period. Finally, Bank of Montreal Can lifted its stake in shares of Monsanto by 75.1% in the 4th quarter. Bank of Montreal Can now owns 1,043,409 shares of the basic materials company’s stock worth $121,850,000 after purchasing an additional 447,662 shares during the period. 75.37% of the stock is currently owned by hedge funds and other institutional investors.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the sale, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.79% of the stock is currently owned by company insiders.

Several equities analysts have recently weighed in on MON shares. Wells Fargo & Co increased their price objective on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Barclays reiterated an “equal weight” rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Finally, Macquarie cut shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and an average price target of $127.30.

Monsanto (NYSE:MON) traded down $0.91 during midday trading on Thursday, reaching $118.81. 3,494,500 shares of the company’s stock were exchanged, compared to its average volume of 3,693,373. Monsanto has a 12 month low of $106.97 and a 12 month high of $122.79. The company has a market cap of $52,300.00, a PE ratio of 21.96, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28.

Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the previous year, the business posted $0.21 EPS. Monsanto’s revenue was up .3% on a year-over-year basis. sell-side analysts predict that Monsanto will post 5.76 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s payout ratio is 39.93%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/18/monsanto-mon-stake-lessened-by-endurance-wealth-management-inc.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply